Type 1 diabetes associated with immune checkpoint inhibitors for malignant melanoma: A case report and review of 8 cases

Advanced malignant melanoma (MM) is treated with immune checkpoint inhibitor (ICI) therapy, which often results in several immune-related adverse events. Fulminant type 1 diabetes mellitus (T1DM) is a rare, rapidly progressive, life-threatening disease. Here, we summarize 8 cases of MM with ICI-indu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishiguro, Akihiro, Ogata, Dai, Ohashi, Ken, Hiki, Kojiro, Yamakawa, Kohei, Jinnai, Shunichi, Tsutsui, Keita, Takahashi, Akira, Namikawa, Kenjiro, Yamazaki, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439787/
https://www.ncbi.nlm.nih.gov/pubmed/36107581
http://dx.doi.org/10.1097/MD.0000000000030398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439787/
https://www.ncbi.nlm.nih.gov/pubmed/36107581
http://dx.doi.org/10.1097/MD.0000000000030398

Ejemplares similares